Simulating clinical trials before patients enroll
Pharma is moving from AI-driven drug discovery to AI-driven trial simulation to fix a costly ninety percent failure rate.
August 5, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🧪 Drug Discovery.
Pathos AI Bets Big on Clinical Rescue
A young startup is spending hundreds of millions to prove that artificial intelligence can salvage stalled drug pipelines.
August 4, 2026
AI catches clinical trial reporting errors cheaply
A new automated tool exposes how easily human editors miss shifted endpoints in published medical research.
August 3, 2026
Eli Lilly Expands TuneLab to Biologics
Big Pharma is learning that keeping proprietary data locked in a vault is no longer the fastest way to win the drug discovery race.
August 1, 2026
GSK Bets Big on Cellular Foundation Models
Big Pharma is shifting its AI strategy from targeting specific diseases to funding the underlying operating system of human biology.
July 30, 2026
Big Pharma Pools Data for Antibody AI
AI drug discovery models are starving for physical data, forcing fierce competitors to pool their proprietary secrets.
July 25, 2026
Betting on FDA Approvals Sparks Ethical Outcry
Treating drug development like a sports book introduces financial incentives that could compromise scientific integrity.
July 22, 2026
Anthropic Targets DeepMind in Biopharma Talent War
The battle for AI supremacy has moved from chatbots to wet labs, and Anthropic is spending heavily to challenge Google’s dominance in drug discovery.
July 20, 2026
Bristol Myers Squibb Builds Custom Nvidia Supercomputer
Drug discovery is no longer just a biology problem; it is a massive infrastructure war.
July 20, 2026
Can AI replace animal testing in five years?
The UK is betting £75 million that algorithms can replace animals in drug safety trials, but the regulatory hurdles remain immense.
July 18, 2026